53 related articles for article (PubMed ID: 1692536)
1. Hematologic and cytogenetic findings in myelodysplastic syndromes treated with recombinant human granulocyte colony-stimulating factor.
Ohyashiki K; Ohyashiki JH; Toyama K; Takaku F
Jpn J Cancer Res; 1989 Sep; 80(9):848-54. PubMed ID: 2480943
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human granulocyte colony stimulating factor (rhG-CSF) participates in the progression of implantation via the hsa_circ_0001550-miRNA-mRNA interaction network.
Lyu M; Su A; Zhang L; Gao W; Liu K; Yue F; Jing Y; Ma X; Liu L
Hum Fertil (Camb); 2023 Dec; 26(5):1061-1072. PubMed ID: 35791760
[TBL] [Abstract][Full Text] [Related]
3. Site-selective fatty acid chain conjugation of the N-terminus of the recombinant human granulocyte colony-stimulating factor.
Wang XD; Su ZH; Du J; Yu WJ; Sun WL
Front Bioeng Biotechnol; 2024; 12():1360506. PubMed ID: 38576447
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous Four-Week Repeated Dose Toxicity Studies of Rice Cell-Derived Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Rats.
Ji JE; Lee JM; Choi JM; Choi YH; Kim EK; Chu SJ; Kim SK; Ahn KH; Lee DH; Kim HH; Han K; Kim DK
Toxicol Res; 2008 Dec; 24(4):315-320. PubMed ID: 32038810
[TBL] [Abstract][Full Text] [Related]
5. Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated.
Abboud R; Keller J; Slade M; DiPersio JF; Westervelt P; Rettig MP; Meier S; Fehniger TA; Abboud CN; Uy GL; Vij R; Trinkaus KM; Schroeder MA; Romee R
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1851-1860. PubMed ID: 27318038
[TBL] [Abstract][Full Text] [Related]
6. An assessment of myeloid colony-forming-cell generation in liquid human bone marrow cultures: influence of accessory cells and cytokines IL-1 alpha, beta and IL-6.
Gooding RP; Riches PG; Gordon MY
Int J Exp Pathol; 1993 Apr; 74(2):173-80. PubMed ID: 8499317
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic management in oncology practice. Part 1. Myeloid growth factors.
Glaspy JA
Oncology (Williston Park); 2003 Nov; 17(11):1593-603. PubMed ID: 14682110
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy with recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Schulz G; Krumwieh D; Oster W
Pharmacol Ther; 1991 Oct; 52(1):85-94. PubMed ID: 1805248
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
Misago M; Chiba S; Kikuchi M; Tsukada J; Sato T; Oda S; Eto S
Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
[TBL] [Abstract][Full Text] [Related]
10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro.
Hara H; Namiki M
Exp Hematol; 1989 Aug; 17(7):816-21. PubMed ID: 2473914
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
Katayama K; Koizumi S; Ueno Y; Ohno I; Ichihara T; Horita S; Miyawaki T; Taniguchi N
Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
